The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Antitumor activity of MLN4924, an investigational inhibitor of NEDD8-activating enzyme (NAE), in preclinical models of melanoma.
T. Traore
Employment or Leadership Position - Millennium
M. Mihollen
Employment or Leadership Position - Millennium
J. Garnsey
Employment or Leadership Position - Millennium
A. Berger
Employment or Leadership Position - Millennium
M. Manfredi
Employment or Leadership Position - Millennium
K. Cosmopolous
Employment or Leadership Position - Millennium
J. Donelan
Employment or Leadership Position - Millennium
P. G. Smith
Employment or Leadership Position - Millennium